p.Asn1180Ile mutation of SCN4A gene in an Italian family with myopathy and myotonic syndrome
- PMID: 34378097
- DOI: 10.1007/s10072-021-05537-z
p.Asn1180Ile mutation of SCN4A gene in an Italian family with myopathy and myotonic syndrome
Abstract
Introduction: Mutations of the skeletal muscle sodium channel gene SCN4A are associated with several neuromuscular disorders including hyper/hypokaliemic periodic paralysis, paramyotonia congenita and sodium channel myotonia. These disorders are distinguished from dystrophic myotonias by the absence of progressive weakness and extramuscular systemic involvement.
Methods: We present an Italian family with 2 subjects carrying a p.Asn1180Ile mutation in SCN4A gene showing a peculiar clinical picture characterized by the association of myopathic features and myotonia.
Results: The clinical, electromyographic and histological findings of these patients are reported. The possible pathogenicity of the mutation was tested by three different software, all giving positive results.
Discussion: This is the first report of a dominant, heterozygous mutation in SCN4A causing a complex phenotype of non-congenital myopathy and myotonic syndrome. We suggest that, in patients with myotonia and myopathy not related to dystrophic myotonias, the sequence analysis of SCN4A gene should be performed.
Keywords: Channellopathies; Mutation; Myopathy; Myotonia; SCN4A.
© 2021. Fondazione Società Italiana di Neurologia.
References
-
- Matthews E, Fialho D, Tan SV, Venance SL, Cannon SC, Sternberg D et al (2010) The non-dystrophic myotonias: molecular pathogenesis, diagnosis and treatment. Brain 133:9–22 - DOI
-
- Stunnenberg BC, LoRusso S, Arnold WD, BarohnRJ CSC, Fontaine B et al (2020) Guidelines on clinical presentation and management of nondystrophic myotonias. Muscle Nerve 62(4):430–444 - DOI
-
- Fournier E, Viala K, Gervais H, Sternberg D, Arzel-Hézode M, Laforêt P et al (2006) Cold extends electromyography distinction between ion channel mutations causing myotonia. Ann Neurol 60(3):356–365 - DOI
-
- Valaperta R, Lombardi F, Cardani R, Fossati B, Brigonzi E, Merli I et al (2015) Development and validation of a new molecular diagnostic assay for detection of myotonic dystrophy type 2. Genet Test Mol Biomarkers 19(12):703–9 - DOI
-
- Galimberti V, Tironi R, Lerario A, Scali M, Del Bo R, Rodolico C et al (2020) Value of insoluble PABPN1 accumulation in the diagnosis of oculopharyngeal muscular dystrophy. Eur J Neurol 27:709–715 - DOI
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
